secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2026-04-29T23:59:59+00:00
Accession:  0001437749-26-013905
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key announces 1-for-10 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------

- Reverse stock split ratio set at 1-for-10, effective 5:00 p.m. ET on April 29, 2026; trading begins split-adjusted April 30, 2026.
- Outstanding shares reduced from ~10,852,118 to ~1,085,212; no fractional shares, rounding up to nearest whole share.
- Stockholders approved the split at an April 20, 2026 special meeting; Board chose the ratio to meet Nasdaq minimum bid price requirement.
- CEO Michael DePasquale stated the split intends to position the stock for bid price compliance while pursuing growth and profitability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774926013905/0001437749-26-013905-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774926013905/bkyi20260429_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-013905

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer